A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 3200 participants.

Also called NCT03947229

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 3,200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03947229
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03947229. Randomized; no masking; primary purpose treatment. Start 2019-08-14 (actual); primary completion 2025-08-16 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial
Condition
DES
Intervention (Drug)
Clopidogrel mono-therapy
Intervention (Drug)
Dual-antiplatelet therapy
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct03947229
Content hash
2dffe3df55e9dfd7d5f3831b134360d05a56afb1893f3296ec206574cc56f13b